Eltrombopag and Romiplostim Used Alternatively in Patients With Immune Thrombopenia (ITP): Efficacy and Safety.

NCT01618734 · clinicaltrials.gov ↗

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Immune Thrombocytopenia
Thrombopoietin Receptor Agonist

Sponsor

Henri Mondor University Hospital

Collaborators

[object Object]